Related Experiment Videos
Interventions promoting adherence to cardiovascular medicines
Judith van Dalem1, Ines Krass, Parisa Aslani
1Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, FAFC Wentgebouw, Sorbonnelaan 16, 3584 CA, Utrecht, The Netherlands. j.vandalem@students.uu.nl
Insights
Behavioral interventions are most effective for improving adherence to cardiovascular medicines. Combining strategies may enhance outcomes, but long-term, multifaceted approaches are crucial for sustained medicine-taking in patients with cardiovascular diseases.
Area of Science:
- Pharmacology and Public Health
- Cardiovascular Medicine
- Health Behavior Research
Background:
- Cardiovascular diseases (CVDs) pose a significant healthcare burden, with low medication adherence impacting treatment efficacy.
- Optimizing adherence and persistence to cardiovascular medications is critical for improving patient health outcomes.
- Identifying effective community-based interventions is essential for enhancing medication adherence in CVD patients.
Purpose of the Study:
- To review literature on community-based interventions aimed at improving adherence to cardiovascular medicines.
- To evaluate the effectiveness of different intervention strategies in patients with hypertension, dyslipidaemia, congestive heart failure, or ischaemic heart disease.
Main Methods:
- A comprehensive literature search was conducted across multiple databases (Medline, EMBASE, etc.) for studies published between 1979 and 2009.
- Eligible studies evaluated interventions to improve adherence to cardiovascular medicines in a community setting, including a comparison/control group.
- Studies were categorized into informational, behavioural, social, and combined strategy interventions.
Main Results:
- Out of 36 eligible studies, 17 reported significant improvements in medication adherence or persistence.
- Behavioural interventions demonstrated the highest success rate in improving adherence compared to informational or social strategies.
- While 21 studies showed improvements in clinical outcomes, these effects were variable and not consistently linked to adherence changes.
Conclusions:
- Various interventions can effectively improve adherence and persistence to cardiovascular medicines in community settings.
- Behavioural interventions are the most successful, with no additional benefit observed from combining informational strategies.
- Sustained improvement in medication adherence requires long-term, multifaceted interventions addressing the dynamic nature of patient behavior.
Background:
Cardiovascular diseases (CVDs) are a large burden on the healthcare system. Medicines are the primary treatment for these diseases; however, adherence to therapy is low. To optimise treatment and health outcomes for patients, it is important that adherence to cardiovascular medicines is maintained at an optimal level. Therefore, identifying effective interventions to improve adherence and persistence to cardiovascular therapy is of great significance.
Aim Of The Review:
This paper presents a review of the literature on interventions used in the community setting which aim to improve adherence to cardiovascular medicines in patients with hypertension, dyslipidaemia, congestive heart failure or ischaemic heart disease.
Methods:
Several databases (Medline, EMBASE, PsychINFO, IPA, CINAHL, Pubmed, Cochrane) were searched for studies which were published from 1979-2009, evaluated interventions intended to improve adherence to cardiovascular medicines in the community setting, had at least one measure of adherence, and consisted of an intervention and comparison/control group.
Results:
Among 36 eligible studies (consisting of 7 informational, 15 behavioural, 1 social, and 13 combined strategy interventions), 17 (1 informational, 10 behavioural, and 6 combined) reported a significant improvement in adherence and/or persistence. Behavioural interventions were the most successful. Twenty-one studies (4 informational, 9 behavioural, and 8 combined) also demonstrated improvements in clinical outcomes, though, effects were frequently variable, contradictory and not related to changes in adherence.
Conclusion:
Several types of interventions are effective in improving adherence and/or persistence within the CVD area and in the community setting. Behavioural interventions have shown the greatest success (compared to other types of interventions); and adding informational strategies has not resulted in further improvements in adherence. Improving adherence and persistence to cardiovascular medicines is a dynamic process that is influenced by many factors, and one which requires long term multiple interventions to promote medicine taking in patients.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Heart Failure V: Medical Management
Coronary Artery Disease IV: Preventive Measures
Peripheral Artery Disease III: Interprofessional Care